Subclinical central inflammation is risk for RIS and CIS conversion to MS

Radiologically Isolated Syndrome: 5-Year Risk for an Initial Clinical Event

(2014) Darin T. Okuda et al.   PLoS One

Cerebrospinal-fluid cytokine and chemokine profile in patients with pneumococcal and meningococcal meningitis

(2013) Leonam G Coutinho et al.   BMC INFECTIOUS DISEASES

Neutrophils Amplify Autoimmune Central Nervous System Infiltrates by Maturing Local APCs

(2013) K. Steinbach et al.   JOURNAL OF IMMUNOLOGY

Synaptic Plasticity and PDGF Signaling Defects Underlie Clinical Progression in Multiple Sclerosis

(2013) F. Mori et al.   JOURNAL OF NEUROSCIENCE

Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration

(2013) Silvia Rossi et al.   Multiple Sclerosis Journal

Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis

(2012) A. Giorgio et al.   NEUROLOGY

Cerebrospinal Fluid IL-12p40, CXCL13 and IL-8 as a Combinatorial Biomarker of Active Intrathecal Inflammation

(2012) Bibiana Bielekova et al.   PLoS One

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis

(2011) Silvia Rossi et al.   ANNALS OF NEUROLOGY

Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome

(2011) D. T. Okuda et al.   NEUROLOGY

The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability

(2010) Antonio Scalfari et al.   BRAIN

The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)

(2010) Johannes Brettschneider et al.   PLoS One

Association Between Clinical Conversion to Multiple Sclerosis in Radiologically Isolated Syndrome and Magnetic Resonance Imaging, Cerebrospinal Fluid, and Visual Evoked Potential

(2009) Christine Lebrun   ARCHIVES OF NEUROLOGY

Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta

(2009) Giancarlo Comi   CLINICAL THERAPEUTICS

Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid

(2009) J. Mellergård et al.   Multiple Sclerosis Journal

Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS

(2009) F. Sellebjerg et al.   NEUROLOGY

Differential diagnosis of suspected multiple sclerosis: a consensus approach

(2008) DH Miller et al.   Multiple Sclerosis Journal

Incidental MRI anomalies suggestive of multiple sclerosis: The radiologically isolated syndrome

(2008) D. T. Okuda et al.   NEUROLOGY